These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Agents against cytokine synthesis or receptors. Yamagata T; Ichinose M Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies for the treatment of asthma. Catley MC; Coote J; Bari M; Tomlinson KL Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943 [TBL] [Abstract][Full Text] [Related]
5. Targeting airway inflammation: novel therapies for the treatment of asthma. Walsh GM Curr Med Chem; 2006; 13(25):3105-11. PubMed ID: 17073650 [TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. van der Velden VH Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333 [TBL] [Abstract][Full Text] [Related]
7. New concepts in the pathogenesis and treatment of allergic asthma. Grayson MH; Bochner BS Mt Sinai J Med; 1998 Sep; 65(4):246-56. PubMed ID: 9757744 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin E blockade in the treatment of asthma. Kuhn R Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896 [TBL] [Abstract][Full Text] [Related]
9. Time for a paradigm shift in asthma treatment: from relieving bronchospasm to controlling systemic inflammation. Bjermer L J Allergy Clin Immunol; 2007 Dec; 120(6):1269-75. PubMed ID: 18073122 [TBL] [Abstract][Full Text] [Related]
10. Potential and novel therapies for asthma. Babu KS; Holgate ST J Assoc Physicians India; 2000 Nov; 48(11):1096-102. PubMed ID: 11310390 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin E-mediated airway inflammation is active in most patients with asthma. Hayden ML J Am Acad Nurse Pract; 2007 Sep; 19(9):439-49. PubMed ID: 17760568 [TBL] [Abstract][Full Text] [Related]
12. Cytokine modulators as novel therapies for asthma. Barnes PJ Annu Rev Pharmacol Toxicol; 2002; 42():81-98. PubMed ID: 11807165 [TBL] [Abstract][Full Text] [Related]
13. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases. D'Amato G Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445 [TBL] [Abstract][Full Text] [Related]
14. New drugs for asthma. Barnes PJ Nat Rev Drug Discov; 2004 Oct; 3(10):831-44. PubMed ID: 15459674 [TBL] [Abstract][Full Text] [Related]
15. New therapies for asthma: is there any progress? Barnes PJ Trends Pharmacol Sci; 2010 Jul; 31(7):335-43. PubMed ID: 20554041 [TBL] [Abstract][Full Text] [Related]
16. Novel and emerging therapies for asthma. Leath TM; Singla M; Peters SP Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825 [TBL] [Abstract][Full Text] [Related]
18. New advances in the pathogenesis and therapy of bronchial asthma. Ricci M; Matucci A; Rossi O Ann Ital Med Int; 1998; 13(2):93-110. PubMed ID: 9734142 [TBL] [Abstract][Full Text] [Related]
19. [The future of asthma therapy]. Solèr M Schweiz Med Wochenschr; 2000 Feb; 130(8):277-81. PubMed ID: 10726286 [TBL] [Abstract][Full Text] [Related]
20. An update on emerging drugs for asthma. Walsh GM Expert Opin Emerg Drugs; 2012 Mar; 17(1):37-42. PubMed ID: 22292562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]